| Literature DB >> 34085925 |
Timurs Maculins1,2, Erik Verschueren3, Trent Hinkle3, Meena Choi3,4, Patrick Chang5, Cecile Chalouni5, Shilpa Rao6, Youngsu Kwon7, Junghyun Lim1, Anand Kumar Katakam5, Ryan C Kunz8, Brian K Erickson8, Ting Huang4, Tsung-Heng Tsai4,9, Olga Vitek4, Mike Reichelt5, Yasin Senbabaoglu6, Brent Mckenzie7, John R Rohde10, Ivan Dikic2,11, Donald S Kirkpatrick12, Aditya Murthy12.
Abstract
Defective autophagy is strongly associated with chronic inflammation. Loss-of-function of the core autophagy gene Atg16l1 increases risk for Crohn's disease in part by enhancing innate immunity through myeloid cells such as macrophages. However, autophagy is also recognized as a mechanism for clearance of certain intracellular pathogens. These divergent observations prompted a re-evaluation of ATG16L1 in innate antimicrobial immunity. In this study, we found that loss of Atg16l1 in myeloid cells enhanced the killing of virulent Shigella flexneri (S.flexneri), a clinically relevant enteric bacterium that resides within the cytosol by escaping from membrane-bound compartments. Quantitative multiplexed proteomics of murine bone marrow-derived macrophages revealed that ATG16L1 deficiency significantly upregulated proteins involved in the glutathione-mediated antioxidant response to compensate for elevated oxidative stress, which simultaneously promoted S.flexneri killing. Consistent with this, myeloid-specific deletion of Atg16l1 in mice accelerated bacterial clearance in vitro and in vivo. Pharmacological induction of oxidative stress through suppression of cysteine import enhanced microbial clearance by macrophages. Conversely, antioxidant treatment of macrophages permitted S.flexneri proliferation. These findings demonstrate that control of oxidative stress by ATG16L1 and autophagy regulates antimicrobial immunity against intracellular pathogens.Entities:
Keywords: autophagy; cell biology; immunology; inflammation; macrophages; mass spectrometry; mouse; oxidative damage; proteomics; shigella flexneri
Year: 2021 PMID: 34085925 PMCID: PMC8177894 DOI: 10.7554/eLife.62320
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140